While, METTL3 has been found to be upregulated in prostate cancer, and METTL3 increases the cell proliferation and migration of prostate cancer cells by activating expression of LEF1 or Myc in an m6A methylation dependent manner211,212 (Fig. 7). Here, MYC is linked to prostate carcinoma.